• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Abbott grants $1.6M to ADA in new diabetes collaboration

August 22, 2024 By Sean Whooley

Abbott logo updatedAbbott (NYSE:ABT) and the American Diabetes Association (ADA) announced a collaboration to support people with diabetes, obesity and metabolic dysfunction.

Through the collaboration, ADA plans to review and consolidate evidence to help healthcare professionals understand the unique nutritional needs associated with diabetes, obesity and metabolic dysfunction. ADA also intends to assess the role nutrition formulas play in health.

Abbott and the ADA already have a collaboration — entered into last year — focused on improving nutrition for people with diabetes. It aims to better understand how diabetes technologies, like CGMs made by Abbott, can help people with diabetes make informed decisions about food and activity.

“Abbott and the ADA are both science-based organizations with a long history in research, education, and helping people live healthier lives,” said Joe Manning, EVP for Abbott’s nutrition business. “We look forward to working with the ADA to help equip health care professionals with nutrition resources and information to support people living with diabetes and obesity.”

This new collaboration builds on that commitment to supporting those with diabetes, while extending support to those with obesity. Abbott agreed to provide a $1.6 million grant over the next three years for the ADA.

Abbott’s funding allows the ADA to engage and convene top health experts to discuss and evaluate nutritional support. The association can also gather, review and synthesize the latest scientific evidence on nutritional needs. Researchers can incorporate their findings into publications in peer-reviewed journals, the ADA Scholars Program and healthcare professional education.

“Better understanding nutritional needs will help health care professionals support their patients and get ahead of nutritional problems,” said Charles “Chuck” Henderson, CEO of the ADA. “This collaboration with Abbott aims to bridge the gap in practical nutrition guidance, addressing the specific malnutrition challenges faced by people with diabetes, which aligns with the ADA’s mission to improve the lives of people impacted by diabetes as well as the work of our newly formed Obesity Association to reduce the prevalence of obesity.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: abbott, American Diabetes Association

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS